FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

4074401000001100: Report all adverse reactions to the CSM (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2004. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
10072501000001113 Report all adverse reactions to the CSM en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
36829301000001115 Report all adverse reactions to the CSM (qualifier value) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Report all adverse reactions to the CSM Is a CSM warning status messages true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
NovoNorm 2mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Atosiban 37.5mg/5mL infusion concentrate - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Atosiban 6.75mg/0.9mL injection - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Tractocile 37.5mg/5mL infusion concentrate CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Tractocile 6.75mg/0.9mL injection CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Orgalutran 0.25mg/0.5mL prefilled syringe CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Cetrorelix 3mg injection (pdr for recon)+solvent - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Cetrorelix 0.25mg injection (pdr for recon)+solvent - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Trospium chloride 20mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Regurin 20mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ethinylestradiol+drospirenone 30micrograms/3mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Yasmin tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ganirelix 0.25mg/0.5mL prefilled syringe - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Nateglinide 60mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Nateglinide 120mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Nateglinide 180mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Starlix 180mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Starlix 120mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Starlix 60mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Pioglitazone 15mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Cetrotide 3mg injection (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Cetrotide 0.25mg injection (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
NovoMix 30 FlexPen 100units/mL injection prefilled pen 3mL CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
NovoMix 30 Penfill 100units/mL injection cartridge 3mL CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Evista 60mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Raloxifene hydrochloride 60mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Rosiglitazone 8mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Rosiglitazone 4mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Actos 15mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Pioglitazone 30mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Actos 30mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Avandia 8mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Avandia 4mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Immucyst injection (pdr for recon)+diluent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Connaught strain Bacillus Calmette-Guerin injection (pdr for recon)+diluent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
INVANZ 1g i-v infusion (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ertapenem 1g i-v infusion (pdr for recon) - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Linezolid 600mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Linezolid 600mg/300mL infusion solution - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Linezolid 100mg/5mL granules for oral suspension CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Zyvox 100mg/5mL granules for oral suspension CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Zyvox 600mg/300mL infusion solution CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Zyvox 600mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Quinupristin+dalfopristin 150mg/350mg infusion (pdr for recon) - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Synercid infusion (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ketek 400mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Telithromycin 400mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Insulin glargine 100iu/mL prefilled pen - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Insulin glargine 100iu/mL injection vial - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Insulin glargine 100iu/mL injection cartridge - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Insulin aspart 100units/mL cartridge - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Insulin aspart 100units/mL prefilled syringe - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Insulin aspart 100units/mL injection vial - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Insulin aspart 100units/mL prefilled pen - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
NovoRapid 100units/mL injection vial CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Insulin lispro 100iu/mL prefilled pen - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Estradiol hemihydrate 150micrograms nasal spray - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Aerodiol 150micrograms nasal spray CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Malarone tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Atovaquone+proguanil hydrochloride 250mg/100mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Efavirenz 50mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Efavirenz 30mg/mL oral solution - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Sustiva 30mg/mL oral solution CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Sustiva 200mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Sustiva 100mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Sustiva 50mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Nevirapine 50mg/5mL oral suspension - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Viramune 50mg/5mL oral suspension CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Viramune 200mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Nevirapine 200mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Raxar 600mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Raxar 400mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Grepafloxacin 600mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Grepafloxacin 400mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Oseltamivir 12mg/mL oral suspension - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Oseltamivir 75mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Valcyte 450mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Valganciclovir 450mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Viread 245mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Tenofovir disoproxil 245mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Lopinavir+ritonavir 133.3mg/33.3mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Lopinavir+ritonavir 400mg/100mg/5mL oral solution - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Kaletra 400mg/100mg/5mL oral solution CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Kaletra 133.3mg/33.3mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Trizivir tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Amprenavir 50mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Amprenavir 150mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Amprenavir 15mg/mL oral solution - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Agenerase 15mg/mL oral solution CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Agenerase 150mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Agenerase 50mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Palivizumab 100mg injection (pdr for recon)+solvent - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Palivizumab 50mg injection (pdr for recon)+solvent - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Synagis 100mg injection (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Synagis 50mg injection (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Abacavir 20mg/mL oral solution - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Abacavir 300mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ziagen 20mg/mL oral solution CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ziagen 300mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Efavirenz 200mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Efavirenz 100mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier

Page 1 of 8 Next End

This concept is not in any reference sets

Back to Start